TRCT
GNFT

Tower Research Capital (TRC)’s Genfit GNFT Stock Holding History

Tower Research Capital (TRC)’s Portfolio GNFT Stock Details GNFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,069
Closed -$4K – 6078
2022
Q3 		$4K Buy
+1,069
New +$4.47K ﹤0.01% 5253
2022
Q2 		– Sell
-1,260
Closed -$5K – 6230
2022
Q1 		$5K Buy
+1,260
New +$5.15K ﹤0.01% 5051
2021
Q4 		– Sell
-85
Closed – – 6294
2021
Q3 		$0 Sell
85
-200
-70% -$763 ﹤0.01% 5905
2021
Q2 		$1K Buy
+285
New +$1.2K ﹤0.01% 5207
2019
Q4 		– Sell
-64
Closed -$1K – 3827
2019
Q3 		$1K Sell
64
-245
-79% -$4.28K ﹤0.01% 3861
2019
Q2 		$6K Buy
+309
New +$7.23K ﹤0.01% 2844

Other funds holding GNFT

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Optiver Holding
Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return

Tower Research Capital (TRC)'s GNFT Position: Q4 2022 in Review

Tower Research Capital (TRC) sold out of Genfit (GNFT) in Q4 2022, closing a stake of 1,069 shares — an estimated $4K sold.

Tower Research Capital (TRC) first reported a position in GNFT in Q2 2019 and held it in 6 quarters. The position peaked at $6K in Q2 2019. 15 funds tracked by Wall St. Rank hold GNFT as of Q4 2022.

  • Tower Research Capital (TRC) reported no remaining Genfit position as of Q4 2022 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 1,069 Genfit shares in Q4 2022, an estimated $4K.
  • Tower Research Capital (TRC) first reported a position in Genfit in Q2 2019 and held it in 6 quarters.
  • Tower Research Capital (TRC)'s Genfit position peaked at $6K in Q2 2019.
  • 15 funds tracked by Wall St. Rank held Genfit as of Q4 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.